Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2017 1
2018 4
2019 3
2020 12
2021 12
2022 7
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Electrophilic warheads in covalent drug discovery: an overview.
Péczka N, Orgován Z, Ábrányi-Balogh P, Keserű GM. Péczka N, et al. Among authors: abranyi balogh p. Expert Opin Drug Discov. 2022 Apr;17(4):413-422. doi: 10.1080/17460441.2022.2034783. Epub 2022 Feb 6. Expert Opin Drug Discov. 2022. PMID: 35129005 Review.
Covalent fragment approaches targeting non-cysteine residues.
Csorba N, Ábrányi-Balogh P, Keserű GM. Csorba N, et al. Among authors: abranyi balogh p. Trends Pharmacol Sci. 2023 Nov;44(11):802-816. doi: 10.1016/j.tips.2023.08.014. Epub 2023 Sep 26. Trends Pharmacol Sci. 2023. PMID: 37770315 Free article. Review.
Covalent fragment libraries in drug discovery.
Keeley A, Petri L, Ábrányi-Balogh P, Keserű GM. Keeley A, et al. Among authors: abranyi balogh p. Drug Discov Today. 2020 Jun;25(6):983-996. doi: 10.1016/j.drudis.2020.03.016. Epub 2020 Apr 13. Drug Discov Today. 2020. PMID: 32298798 Free article. Review.
Discovery of selective fragment-sized immunoproteasome inhibitors.
Kollár L, Gobec M, Szilágyi B, Proj M, Knez D, Ábrányi-Balogh P, Petri L, Imre T, Bajusz D, Ferenczy GG, Gobec S, Keserű GM, Sosič I. Kollár L, et al. Among authors: abranyi balogh p. Eur J Med Chem. 2021 Jul 5;219:113455. doi: 10.1016/j.ejmech.2021.113455. Epub 2021 Apr 20. Eur J Med Chem. 2021. PMID: 33894528
Cysteine specific bioconjugation with benzyl isothiocyanates.
Petri L, Szijj PA, Kelemen Á, Imre T, Gömöry Á, Lee MTW, Hegedűs K, Ábrányi-Balogh P, Chudasama V, Keserű GM. Petri L, et al. Among authors: abranyi balogh p. RSC Adv. 2020 Apr 16;10(25):14928-14936. doi: 10.1039/d0ra02934c. eCollection 2020 Apr 8. RSC Adv. 2020. PMID: 35497170 Free PMC article.
Activation-Free Sulfonyl Fluoride Probes for Fragment Screening.
Petri L, Ábrányi-Balogh P, Csorba N, Keeley A, Simon J, Ranđelović I, Tóvári J, Schlosser G, Szabó D, Drahos L, Keserű GM. Petri L, et al. Among authors: abranyi balogh p. Molecules. 2023 Mar 29;28(7):3042. doi: 10.3390/molecules28073042. Molecules. 2023. PMID: 37049805 Free PMC article.
Heterocyclic electrophiles as new MurA inhibitors.
Keeley A, Ábrányi-Balogh P, Hrast M, Imre T, Ilaš J, Gobec S, Keserű GM. Keeley A, et al. Among authors: abranyi balogh p. Arch Pharm (Weinheim). 2018 Dec;351(12):e1800184. doi: 10.1002/ardp.201800184. Epub 2018 Nov 21. Arch Pharm (Weinheim). 2018. PMID: 30461051
Comparative reactivity analysis of small-molecule thiol surrogates.
Petri L, Ábrányi-Balogh P, Varga PR, Imre T, Keserű GM. Petri L, et al. Among authors: abranyi balogh p. Bioorg Med Chem. 2020 Apr 1;28(7):115357. doi: 10.1016/j.bmc.2020.115357. Epub 2020 Feb 11. Bioorg Med Chem. 2020. PMID: 32081630 Free article.
Covalent Inhibition of the Histamine H3 Receptor.
Wágner G, Mocking TAM, Kooistra AJ, Slynko I, Ábrányi-Balogh P, Keserű GM, Wijtmans M, Vischer HF, de Esch IJP, Leurs R. Wágner G, et al. Among authors: abranyi balogh p. Molecules. 2019 Dec 11;24(24):4541. doi: 10.3390/molecules24244541. Molecules. 2019. PMID: 31835873 Free PMC article.
45 results